A printable hydrogel microarray for drug screening avoids false positives associated with promiscuous aggregating inhibitors
False positive results significantly slow down the drug discovery process. Here, the authors developed a gel serving as a screening platform in which enzymes can be stored, stabilized, and protected from most of the compounds that typically cause these misleading results.
Main Authors: | Rabia Mateen, M. Monsur Ali, Todd Hoare |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-02956-z |
Similar Items
-
Review of 3D printable hydrogels and constructs
by: Huijun Li, et al.
Published: (2018-12-01) -
3D Printability of Alginate-Carboxymethyl Cellulose Hydrogel
by: Ahasan Habib, et al.
Published: (2018-03-01) -
The cytological component of cervical cancer screening: causes of false negative and false positive results, and ways to avoid them
by: O.A. Burka, et al.
Published: (2021-03-01) -
Printability of 3D Printed Hydrogel Scaffolds: Influence of Hydrogel Composition and Printing Parameters
by: Saman Naghieh, et al.
Published: (2019-12-01) -
Amphiphilic Triblock Copolymers for 3D Printable and Biodegradable Hydrogels
by: Wang, Zeyu
Published: (2020)